Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$18.17 USD
+0.01 (0.06%)
Updated Jan 2, 2025 04:00 PM ET
After-Market: $18.18 +0.01 (0.06%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Price, Consensus and EPS Surprise
CCRN 18.17 +0.01(0.06%)
Will CCRN be a Portfolio Killer in January?
Zacks Investment Research is releasing its prediction for CCRN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CCRN
Cross Country (CCRN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Cross Country Healthcare (CCRN) Surpasses Q3 Earnings and Revenue Estimates
CCRN: What are Zacks experts saying now?
Zacks Private Portfolio Services
TrueBlue (TBI) Reports Q3 Loss, Misses Revenue Estimates
Is the Options Market Predicting a Spike in Cross Country Healthcare (CCRN) Stock?
Cross Country (CCRN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for CCRN
Cross Country Healthcare (CCRN) Gets a Hold from Truist Financial
Hold Rating for Cross Country Healthcare Amid Acquisition and Market Challenges
Cross Country downgraded to Market Perform from Outperform at Barrington
Cross Country downgraded to Market Perform from Outperform at Barrington
Cross Country Healthcare management to meet with Oppenheimer